News in the Life Sciences Industry

CORK, Ireland, Aug. 22, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have announced positive top-line results from the Phase 3 ATLAS-2M study of the investigational, long-acting two-drug injectable regimen of its rilpivirine and ViiV Healthcare's... Read more ››

DARMSTADT, Germany, Aug. 19, 2019 /PRNewswire/ -- Read more ››

TEL AVIV, Israel, Aug. 14, 2019 /PRNewswire/ -- FDA has cleared Pollogen's RF home-use device - TriPollar Stop - for sale in the US. TriPollar Stop, the innovative home-use device developed by Pollogen, is based on the company's clinically-proven, patented RF technology, and has enjoyed broad... Read more ››

BERLIN and CAMBRIDGE, Mass., Aug. 8, 2019 /PRNewswire/ -- Bayer AG and BlueRock Therapeutics today announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused on developing engineered cell therapies in the... Read more ››

DUBLIN, Aug. 6, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the second quarter of 2019 and updated 2019 financial guidance.

BERLIN, Aug. 6, 2019 /PRNewswire/ -- The privately-owned company, MT.DERM GmbH, Berlin, Germany, a manufacturer of medical microneedling, micropigmentation and tattoo equipment is excited to announce further expansion into the US market of its medical microneedling devices, exclusively available... Read more ››